Work

Faecal leucine levels differentiate paediatric inflammatory bowel disease from irritable bowel syndrome and functional abdominal pain

Year: 2026
Type: article
Study design: Observational Study
Abstract: Diagnosing inflammatory bowel disease (IBD) is based on a combination of clinical symptoms, with laboratory tests and endoscopy, to distinguish IBD from other conditions. Faecal amino acids, particularly leucine, have shown promising results as noninvasive biomarker for this purpose. This cross-sectional study evaluated faecal leucine and the leucine/isoleucine ratio and its potential discriminative value between treatment-naïve IBD patients and patients with irritable bowel syndrome (IBS) and functional abdominal pain- not otherwise specified (FAP-NOS) patients, using a targeted liquid chromatography-mass spectrometry (LC-MS/MS) technique. Absolute leucine concentration and the leucine/isoleucine ratio were significantly higher in IBD, with the leucine/isoleucine ratio showing an area under the curve of 0.75 (95%CI: 0.65-0.84) with a cut-off value of 1.44. Concluding, the leucine/isoleucine ratio can differentiate IBD from IBS and FAP-NOS, and provides insights into disease pathogenesis. These findings highlight its potential as a novel noninvasive biomarker, although further studies are warranted.
Language: English
Field: Medicine
Open Access status: hybrid
Estimated APC paid: $3,780
OpenAlex ID: W7234978312
FWCI:
Cites: 19
Cited by:
Related to: 10